Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2026-01-24 @ 10:28 PM
Study NCT ID:
NCT02877550
Status:
COMPLETED
Last Update Posted:
2022-06-10
First Post:
2016-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Sponsor:
Swiss Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SAKK 35/15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None